Burford Capital Limited logo
Burford Capital Limited BUR
€ 2.95 -6.36%
report update icon

Quartalsbericht 2026-Q3
hinzugefügt 04.11.2026

Burford Capital Limited EV | BUR

EV Jährlich Burford Capital Limited

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
5.73 B 5.67 B 5.37 B 3.75 B 3.77 B 3.22 B 1.35 B 690 M 565 M 372 M 160 M 151 M 24.6 M 12.9 M 12.6 M

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
5.73 B 12.6 M 2.06 B

EV anderer Aktien in der Pharmaeinzelhändler

Name EV Preis % 24h Marktkapitalisierung Land
Repare Therapeutics Repare Therapeutics
RPTX
-9.3 M - - $ 112 M canadaCanada
Sesen Bio Sesen Bio
SESN
66.6 M - 7.29 % $ 127 M usaUSA
Windtree Therapeutics Windtree Therapeutics
WINT
81.3 M - - $ 26.8 M usaUSA
Trean Insurance Group Trean Insurance Group
TIG
1.47 B - - $ 316 M usaUSA
SQZ Biotechnologies Company SQZ Biotechnologies Company
SQZ
-3.96 M - 57.95 % $ 12.8 M usaUSA
MEI Pharma MEI Pharma
MEIP
-4.64 M - 10.43 % $ 20.5 M usaUSA
Palatin Technologies Palatin Technologies
PTN
35.7 M - - $ 13 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
14.1 M - - - russiaRussia
Lyra Therapeutics Lyra Therapeutics
LYRA
30.9 M - - $ 24.9 M usaUSA
Brickell Biotech Brickell Biotech
BBI
515 K - -5.38 % $ 6.06 M usaUSA
Applied Therapeutics Applied Therapeutics
APLT
-49.7 M - - $ 8.42 M usaUSA
ESSA Pharma ESSA Pharma
EPIX
-26.7 M - - $ 8.86 M canadaCanada
Generation Bio Co. Generation Bio Co.
GBIO
68.7 M - - $ 344 M usaUSA
Clearside Biomedical Clearside Biomedical
CLSD
44 M - - $ 25.3 M usaUSA
Merus N.V. Merus N.V.
MRUS
2.82 B - - $ 5.78 B niderlandNiderland
RAPT Therapeutics RAPT Therapeutics
RAPT
-72 M - - $ 2.36 B usaUSA
Annexon Annexon
ANNX
673 M $ 3.11 -8.94 % $ 482 M usaUSA
Acasti Pharma Acasti Pharma
ACST
-14.2 M - 4.01 % $ 150 M canadaCanada
Aptose Biosciences Aptose Biosciences
APTO
36.2 M - -45.71 % $ 1.2 M canadaCanada
Galapagos NV Galapagos NV
GLPG
1.99 B - - $ 1.83 B belgiumBelgium
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCCP
-3.1 M - -4.36 % $ 27 M usaUSA
Avenue Therapeutics Avenue Therapeutics
ATXI
-1.76 M - -52.27 % $ 4.45 M usaUSA
Galmed Pharmaceuticals Ltd. Galmed Pharmaceuticals Ltd.
GLMD
-795 K $ 4.63 21.05 % $ 20 M israelIsrael
Achieve Life Sciences Achieve Life Sciences
ACHV
126 M $ 6.78 0.89 % $ 296 M usaUSA
Leap Therapeutics Leap Therapeutics
LPTX
-4.36 M - 368.57 % $ 41.9 M usaUSA
Lumos Pharma Lumos Pharma
LUMO
2.85 M - - $ 35.3 M usaUSA
Gamida Cell Ltd. Gamida Cell Ltd.
GMDA
283 M - -18.25 % $ 5.04 M israelIsrael
Axcella Health Axcella Health
AXLA
22.6 M - -16.42 % $ 249 M usaUSA
Metacrine Metacrine
MTCR
-35.4 M - - $ 24.2 M usaUSA
Zealand Pharma A/S Zealand Pharma A/S
ZEAL
866 M - 0.52 % $ 821 M danmarkDanmark
Myovant Sciences Ltd. Myovant Sciences Ltd.
MYOV
587 M - -0.04 % $ 2.62 B usaUSA
Bellerophon Therapeutics Bellerophon Therapeutics
BLPH
77.1 M - -74.18 % $ 955 K usaUSA
Idera Pharmaceuticals Idera Pharmaceuticals
IDRA
51.5 M - -23.04 % $ 26.6 M usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
2.99 B - - $ 3.67 B usaUSA
Verona Pharma plc Verona Pharma plc
VRNA
43.8 B - - $ 69.7 B britainBritain
Atreca Atreca
BCEL
94.8 M - -11.76 % $ 5.79 M usaUSA
Guardion Health Sciences Guardion Health Sciences
GHSI
-2.59 M - -0.31 % $ 3.64 M usaUSA
Opiant Pharmaceuticals Opiant Pharmaceuticals
OPNT
102 M - - $ 109 M usaUSA
Akouos Akouos
AKUS
107 M - 0.23 % $ 488 M usaUSA
ImmunoGen ImmunoGen
IMGN
935 M - - $ 7.92 B usaUSA
Vascular Biogenics Ltd. Vascular Biogenics Ltd.
VBLT
-6.87 M - -8.77 % $ 12.4 M israelIsrael
Cidara Therapeutics Cidara Therapeutics
CDTX
9.99 M - - $ 1.41 B usaUSA
Iterum Therapeutics Iterum Therapeutics
ITRM
52.5 M - - $ 591 K irlandaIrlanda
Virpax Pharmaceuticals Virpax Pharmaceuticals
VRPX
1.81 M - -45.12 % $ 2.85 M usaUSA
Navidea Biopharmaceuticals Navidea Biopharmaceuticals
NAVB
19.5 M - -2.99 % $ 2.47 M usaUSA
Stealth BioTherapeutics Corp Stealth BioTherapeutics Corp
MITO
499 M - - $ 23.9 M usaUSA
OncoSec Medical Incorporated OncoSec Medical Incorporated
ONCS
26.7 M - 31.87 % $ 1.61 M usaUSA